CAN - Spark Newswire

3 minute read

38 Stocks Moving In Wednesday’s Mid-Day Session

Today, 8:08 PM

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to purchase Chembio's DPP SARS-CoV-2 Antigen tests for delivery during 2021.

AFI

3 minute read

28 Stocks Moving in Wednesday’s Pre-Market Session

By Lisa Levin

Today, 8:08 PM

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares rose 78.2% to $3.67 in pre-market trading after dropping more than 16% on Tuesday. Chembio’s filing recently showed registration for $60 million common stock offering.

AEHR

1 minute read

Canaan Introduces Self-Developed Edge AI Chip, The Kendryte K510

By Anusuya Lahiri

Today, 8:08 PM

Canaan Inc (NASDAQ:CAN) announced it is launching an independently designed and developed RISC-V-based edge AI chip Kendryte K510 at the 2021…

CAN

1 minute read

News

Canaan Releases Self-developed Edge AI Chip, the Kendryte K510

By Benzinga Newsdesk

Today, 8:08 PM

Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced the release of the Kendryte K510 (the "K510"), an independently

CAN

2 minute read

Analyzing Canaan’s Unusual Options Activity

By Benzinga Insights

Today, 8:08 PM

On Wednesday, shares of Canaan (NASDAQ:CAN) saw unusual options activity. After the option alert, the stock price moved down to $7.12.

CAN

2 minute read

Canaan Announces Agreement With Genesis Digital To Sell 10,000 Bitcoin Mining Machines

By Bill Haddad

Today, 8:08 PM

Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced thatit has secured a purchase order (the "Order") from Genesis

CAN

5 minute read

60 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:08 PM

Gainers RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as monotherapy for moderate-to-severe atopic dermatitis (AD).

AMC

2 minute read

Mid-Afternoon Market Update: Dow Tumbles 250 Points; Enochian Biosciences Shares Spike Higher

By Lisa Levin

Today, 8:08 PM

Toward the end of trading Monday, the Dow traded down 0.74% to 34,225.89 while the NASDAQ rose 0.45% to 14,132.55. The S&P also fell, dropping 0.27% to 4,236.03.

ACN

2 minute read

Mid-Day Market Update: Nasdaq Rises Over 50 Points; Washington Prime Group Shares Plunge

By Lisa Levin

Today, 8:08 PM

Midway through trading Monday, the Dow traded down 0.65% to 34,255.66 while the NASDAQ rose 0.41% to 14,126.79. The S&P also fell, dropping 0.23% to 4,237.53.

ACN

3 minute read

40 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 8:08 PM

Gainers Enochian Biosciences, Inc. (NASDAQ: ENOB) shares jumped 127.2% to $10.02. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request for a potential functional cure or treatment of HIV.

AMC

Feed Symbols: CAN